However, accumulating evidence implicates eosinophils as active players in the pathogenesis of inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn's disease (CD) (1)
By targeting the bodys hunger signals, GLP-1 therapies can reduce caloric intake, support blood sugar control, and promote a feeling of fullness
Intraperitoneal (Systemic): Systemic administration shows efficacy for gut healing, liver protection, and CNS injury, confirming BPC-157s ability to act at distant sites
1 Shot: $40 -or- 6 Shots: $210 (Save $30) Proof of Low Vitamin D lab preferred at the time of appointment
Concurrent treatment: Peptides work best alongside appropriate rehabilitation, not as replacements for physical therapy